Alvotech (ALVO) stock

Biosimilar medicines , market cap $1.7B

Biosimilar medicines for various diseases

Worth $1.7B

$4.67

+2.86%

As of Wednesday's close · Live for Pro members at the open

Quality Score

Below Average

In its industry

#122of 291

Biotech

Checks firing

1of 14

Transition

From 52-week high

-28.5%

under its best in a year

ALVO's Quality Score fell 1 point on Wed, Nov 4, to 1. Trading picked back up.

See ALVO's 14 chart checksSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is ALVO up?

Up 2% on Oct 20 while the S&P 500 rose 0.3%.

“Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch.”

Its release that day said

Sources: Price history, Oct 20, 2026; Company release (8-K), Oct 20, 2026

1 more reason, free with an account →1 more reason why ALVO rose on Oct 20, from its filings, with the timeline and its peers, for Pro members.

Key facts on ALVO

Key facts on ALVO
Holding it back	14.5% more shares than a year ago from Massive's market data
Latest filing	6-K, Oct 20 Issued a release: "Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch"

1 more reason behind ALVO's 1, free with an account →3 more reasons behind ALVO's 1, for Pro members.

ALVO in the news

ReportReports Wednesday, after the close. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, -2.6% on average. Past reports ›

Big story

FDA

Alvotech shares jump premarket after FDA approves new Simlandi process

ALVO closed +1.8% that day.

Reported by Investing.com · covered by 13 outlets

Get an alert on ALVO's next big story →

Outlet counts from the GDELT Project. The move is what ALVO did that session, not a claim about why.

What's next

Tue Nov 17: UBS Global Biopharma Conference 2026Investor conference · date confirmed.

4 more dates ahead: conferences, for Pro members.

ALVO catalysts

Coming up

After its last 4 reports it closed -2.6% on average, higher 1 of 4 times.

3 past catalysts since 2026, with sizes and sources, for Pro members.Get in free →

Why ALVO scores 1

Below Averagefor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means

+1Chart checks 1 of 14 firing right now, one point each
+2Profit A profit of $27.9M in the year to Dec 31, 2025, after a loss of $232M the year before, from the SEC filingRead on the last four quarters against the four before, or the last full year where no quarters are filed.

Long-term trend subtracts
Run-up adds
Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

No effect today: Size, Growth, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on ALVO and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 12:46 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when ALVO's Quality Score turns up

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on ALVO and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

ALVO has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on ALVO, and all 14 on every stock.Get in free →

ALVO RSI on Nov 4: 41.5, below its 50-day, above its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1441.5
Above 30, below 50.
MACD (12, 26, 9)Below signal
Crossed below its signal line 25 sessions ago.
50-day average$5.29
The price is 11.7% below it.
200-day average$4.20
The price is 11.2% above it.
50/200 crossGolden cross
The 50-day crossed above the 200-day on Sep 16.
ADX 1418.4
Under 25, with +DI below -DI.
Support$4.40
Swing low from Jan 6, 5.8% below the price.
Resistance$5.35
Swing high from Dec 26, 2025, 14.5% above the price.
52-week high$6.53
From Oct 5, 39.8% above the price.
52-week low$2.94
From Jun 3, 37.0% below the price.
Chart patternNone
No triangle, channel, or wedge in the last year.
Bollinger Bands (20, 2)Inside
The bands run from $4.26 to $5.74.
Volume0.8x
Against its 20-day average, for the time of day.

The deep dive on ALVO

What it does and how it makes money1 findingFor Pro members1 finding on what ALVO does and how it makes money, for Pro members
Who holds and trades it1 findingFor Pro members1 finding on who holds and trades ALVO, for Pro members

2 more findings on ALVO, each with its source, for Pro membersGet in free →

How ALVO ranks in Biotech

ALVO is #122 of 291 by Quality Score.

How ALVO ranks in Biotech
1	KNSAKiniksa Pharmaceuticals International	7/14	23
2	AMGNAmgen	8/14	23
3	ARQTArcutis Biotherapeutics	9/14	22
	ALNYAlnylam Pharmaceuticals		Open for its score
	ALTAltimmune		Open for its score
	ALXOALX Oncology		Open for its score
122	ALVOAlvotech	1/14	1

When does ALVO report earnings, and what happens after?

Reports Wed Nov 11, after the close (in 6 days). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

-5.8%-10.4%+7.0%

Mar 18May 6Aug 19

Reported	When	Gap	Reaction	5 sessions
Aug 19, 2026After close	After close	-2.5%	+7.0%	+23.1%
May 6, 2026After close	After close	-7.3%	-10.4%	+2.8%
Mar 18, 2026After close	After close	-3.7%	-5.8%	-17.4%

ALVO closed higher after 1 of its last 4 reports.

All 4 reports, and ALVO's Quality Score going into each

Everyone reporting earnings next week

ALVO share count over time

Shares of ALVO outstanding, as filed
Shares outstanding	As of
312M	Dec 31, 2025
301.8M	Dec 31, 2024
266.8M	Dec 31, 2023
248.6M	Dec 31, 2022

Offerings, shelves, and splits of ALVO, from its filings
From its filings	Filed
Registered shares for a later sale (F-3ASR)	Jul 28, 2025
Registered shares for a later sale (F-3)	Aug 21, 2024
Set up an at-the-market program for up to $75M of shares, about 4% of its market value	Jun 14, 2024

About Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

1,460 employeesalvotech.com

ALVO's score card

Alvotech (ALVO): Quality Score 1, Below Average, #122 of 291 in Biotech, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn ALVO's score around: 6 things
7 more filings explained, a plain line each
Real-⁠time prices, no delay

See ALVO's 14 chart checks

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 5, 2026: ALVO's Quality Score is 1 (Below Average), #122 of 291 in Biotech.

Is ALVO a good stock to buy? What its Quality Score says

ALVO scores 1 today, which Breakaway calls Below Average. It is #122 of 291 in Biotech by Quality Score, with 1 of 14 chart checks firing. Up 2% on Oct 20 while the S&P 500 rose 0.3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is ALVO's Quality Score?

ALVO scores 1 today, which Breakaway calls Below Average (0 to 5). That is #122 of 291 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ALVO's 1.

When does ALVO report earnings?

Reports Wed Nov 11, after the close, a date the company confirmed. ALVO closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.